US FDA authorizes Eli Lilly's Covid-19 antibody drug
The company on Thursday signed a supply deal with the US government for up to 600,000 doses of bebtelovimab to be delivered by the end of March
The company on Thursday signed a supply deal with the US government for up to 600,000 doses of bebtelovimab to be delivered by the end of March